Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy
Completed · Phase 2 · Has a placebo group
Conditions studied: Epilepsy, Focal Seizures, Partial Seizures
In brief
The primary efficacy objective of the study is to determine if adjunctive therapy of natalizumab 300 mg intravenous (IV) every 4 weeks reduces the frequency of seizures in adult participants with drug-resistant focal epilepsy. The secondary efficacy objective is to assess the effects of natalizumab versus placebo in drug-resistant focal epilepsy on additional measures of seizure frequency.
Key facts
- Study ID
- NCT03283371
- Run by
- Biogen
- People needed
- 67
- Starts
- 2018-03-20
- Expected to finish
- 2020-11-18
- Last updated by the study team
- 2021-12-14
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Research Site — Birmingham, Alabama, United States
- Research Site — Phoenix, Arizona, United States
- Research Site — Phoenix, Arizona, United States
- Research Site — San Diego, California, United States
- Research Site — Santa Monica, California, United States
- Research Site — Washington D.C., District of Columbia, United States
- Research Site — Jacksonville, Florida, United States
- Research Site — Maitland, Florida, United States
- Research Site — Orlando, Florida, United States
- Research Site — Tallahassee, Florida, United States
- Research Site — Tampa, Florida, United States
- Research Site — Honolulu, Hawaii, United States
- Research Site — Chicago, Illinois, United States
- Research Site — Bethesda, Maryland, United States
- Research Site — Chevy Chase, Maryland, United States
- Research Site — Boston, Massachusetts, United States
- Research Site — Boston, Massachusetts, United States
- Research Site — Saginaw, Michigan, United States
- Research Site — St Louis, Missouri, United States
- Research Site — Camden, New Jersey, United States
- Research Site — Rochester, New York, United States
- Research Site — Syracuse, New York, United States
- Research Site — The Bronx, New York, United States
- Research Site — Asheville, North Carolina, United States
- Research Site — Chapel Hill, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.